Drink HRW Newsroom - Profile and News Archive

Drink HRW is on a mission to revolutionize the supplement industry with a new, science-based approach. In just 4 years of availability, various research teams have published 7 clinical trials and 2 case studies using their products, with an additional 15+ clinical trials and 4 preclinical research programs underway. Further, the Drink HRW technology is the only molecular hydrogen supplement on the market to obtain New Dietary Ingredient status after filing with the U.S. FDA.

Engage with Drink HRW

Learn more online at: https://drinkhrw.com/

Follow:   |  Facebook

RSS News Feed for Drink HRW

Press Releases from Drink HRW :

Drink HRW Hydrogen Tablets Outperform Caffeine in Improving Brain Metabolism After Sleep Deprivation

drinkHRW

COQUITIAM, B.C., July 21, 2021 (SEND2PRESS NEWSWIRE) — The COVID-19 pandemic is creating unprecedented levels of sleep deprivation, which presents a significant risk to mental and physical health, says Drink HRW. Additionally, “COVID-somnia,” a term coined to describe the rising prevalence of insomnia following COVID-19 infection, has begun to emerge.

Drink HRW Announces Approval of Registration and Distribution Agreement in Russia

drinkHRW

COQUITIAM, British Columbia, June 8, 2021 (SEND2PRESS NEWSWIRE) — Drink HRW, the industry leader in effervescent tablets to create hydrogen-rich water on demand, announced that they had signed an exclusive partnership with ViloVit, a Russian company dedicated to bringing leading health products to the Russian market, for distribution of Drink HRW branded products across the Eurasian Economic Union, made up of Russia, Kazakhstan, Belarus, Armenia and Kyrgyzstan.

Drink HRW Releases BOOST and BUILD – Ultimate Pre-Workout Performance Supplements

drinkHRW

LOS ANGELES, Calif., March 15, 2021 (SEND2PRESS NEWSWIRE) — Drink HRW, the company that revolutionized the supplement industry with its molecular hydrogen tablets, now releases BOOST and BUILD – Ultimate Pre-Workout Performance Supplements.

Drink HRW Reports on Start of Large-Scale Randomized Controlled Trial and Preliminary Findings from Pilot Trial on the Reduction in Complications from COVID-19

Drink HRW

COQUITLAM, BC, Canada, Jan. 19, 2021 (SEND2PRESS NEWSWIRE) — Drink HRW is excited to announce that a large, double-blind placebo-controlled trial is set to begin this week in France, initiated by the University of Grenoble-Alpes. At the request of the researchers, Drink HRW is supplying the hydrogen tablets for the study as well as a donation to improve the size and scope of the research. It has no other involvement in the research or the decision to publish results.